References
- BoseIli E, Allaouchiche B. Diffusion osseuse des antibio-tiques. Presse Med 1999; 28: 2265–2276.
- Lim VK, Halijah MY. A comparative study of the in-vitro activity of cefepime and other cephalosporins. Malays J Pathol 1993; 15: 65–68.
- Sanders CC. Cefepime: the next generation? Clin Infect Dis 1993; 17: 369–379.
- Wynd MA, Paladino JA. Cefepime: a fourth-generation parenteral cephalosporin. Ann Pharmacother 1996; 30: 1414–1424.
- Okamoto MP, Nakahiro RK, Chin A, Bedikian A, Gill MA. Cefepime: a new fourth-generation cephalosporin. Am J Hosp Pharm 1994; 51: 463–477; quiz 541-462.
- Okamoto MP, Nakahiro RK, Chin A, Bedikian A. Cefepime clinical pharmacokinetics. Clin Pharmacokinet 1993; 25: 88–102.
- Breilh D, Lavallee C, Fratta A, Ducint D, Cony-Makhoul P, Saux MC. Determination of cefepime and cefpirome in human serum by high-performance liquid chromatography using an ultrafiltration for antibiotics serum extraction. J Chromatogr B Biomed Sci Appl 1999; 734: 121–127.
- Lovering AM, Perez J, Bowker KE, Reeves DS, MacGowan AP, Bannister G. A comparison of the penetra-tion of cefuroxime and cephamandole into bone, fat and haematoma fluid in patients undergoing total hip replacement. J Antimicrob Chemother 1997; 40: 99–104.
- Ellner PD, Neu HC. The inhibitory quotient. A method for interpreting minimum inhibitory concentration data. JAMA 1981; 246: 1575–1578.
- Petitjean O, Jehl F, Tod M. Penetration tissulaire des antibiotiques. In: Martin C, Gouin F, eds. Infections et antibio-therapie en reanimation, aux urgences et en chirurgie. Rueil-Malmaison: Arnette. 2001: 1029-1103.
- Souza E, Munoz P. Micro-organisms responsible for osteo-articular infections. Baillieres Best Pract Res Clin Rheumatol 1999; 13: 21–35.
- Hardin TC, Jennings TS. Cefepime. Pharmacotherapy 1994; 14: 657–668.
- Jauregui L, Matzke D, Scott M, Minns P, Hageage G. Cefepime as treatment for osteomyelitis and other severe bac-terial infections. J Antimicrob Chemother 1993; 32 Suppl B: 141-149.
- Wittmann DH, Schassand HH, Faitag V. Pharmacokinetics studies and results of a clinical trial with cefotaxime (HR-756). In: Nelson JD, Grassi C, eds. Current chemotherapy and infectious diseases. Washington, DC: American Society for Microbiology. 1980: 114-116.
- Braga PC, Pozzato C, Cedrini C, et al. Clinical phar-macokinetics of cefotaxime and penetration in sputum, bone, and prostatic tissue. Clin Ther 1982; 5: 69–78.
- Soudry B, Sirot J, Lopitaux R, Dumont C, Delisle JJ, Parenton M. Diffusion de la ceftriaxone dans le tissu osseux humain. Pathol Biol (Paris) 1986; 34: 859–862.
- Leigh DA, Griggs J, Tighe CM, et al. Pharmacokinetic study of ceftazidime in bone and serum of patients undergoing hip and knee arthroplasty. J Antimicrob Chemother 1985; 16: 637–642.